Asesoramiento Financiero julio 2022

Ufenau acquires a majority stake in Dr. Niedermaier Pharma Group

Ufenau Capital Partners has acquired a majority stake in Dr. Niedermaier Pharma Group (“Dr.NIEDERMAIER”), a leading producer and supplier of organic nutritional supplements and natural cosmetics with headquarters in Hohenbrunn near Munich (DE) and in Appenzell (CH).

Founded in 1939, Dr. NIEDERMAIER produces and distributes nutritional supplements, natural cosmetics and beauty liquids in the premium segment based
on the patented "Regulatessence". "Regulatessence" is a highly concentrated, plant-based enzyme digest, which is manufactured in the firm’s own state-of-the-art production facility. With over 50 highly qualified employees, an innovative research team and renowned cooperation partners, Dr. NIEDERMAIER serves a broad and loyal customer base throughout Europe.

Dr. Alexander May, CEO of the international business: "I am extremely pleased to take our company to the next level with Ufenau. We benefit from Ufenau's extensive network, which we will use to place our products in new locationswe have not yet reached."

"It was particularly important to me to find a partner who lives our values and appreciates our tradition - that’s exactly what we have found in Ufenau!", Dr. Cordula Niedermaier-May, Founder of Dr. NIEDERMAIER.

"Dr. NIEDERMAIER is a traditional company with strong brands in the field of nutritional supplements and natural cosmetics. The combination of innovative product development and sales expertise is remarkable. We are pleased to be able to accompany the further growth together with the entire Dr. NIEDERMAIER team and the management in the third generation", Ralf Flore, Managing Partner at Ufenau.

Sancovia supported the buyer with the financial due diligence. 

Ufenau acquires a majority stake in Dr. Niedermaier Pharma Group
Logo von Ufenau Capital Partners
Logo von Dr. Niedermaier Pharma Group